PYC has entered the transactional window – creating optionality with respect to access to capital
PYC THERAPEUTICS“Mid-clinical-stage M&A leading the pack - We are seeing much more M&A this year in Phase 1 and Phase 2 than before. There are fewer platform and Phase 3 deals happening and fewer deals happening at the approved stage”1
- Forums
- ASX - By Stock
- PYC
- Ann: Q2 2024 Investor Webinar Presentation
PYC
pyc therapeutics limited
Add to My Watchlist
3.33%
!
$1.16

Ann: Q2 2024 Investor Webinar Presentation, page-2
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.040(3.33%) |
Mkt cap ! $676.5M |
Open | High | Low | Value | Volume |
$1.18 | $1.20 | $1.15 | $141.8K | 121.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8497 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 2870 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8497 | 1.160 |
1 | 13643 | 1.155 |
6 | 77654 | 1.150 |
2 | 3791 | 1.145 |
2 | 52000 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 1725 | 4 |
1.185 | 8743 | 3 |
1.190 | 1300 | 2 |
1.200 | 11949 | 2 |
1.205 | 2270 | 1 |
Last trade - 15.36pm 18/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online